You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1516558 |
---|---|
Category | Proteins |
Description | Recombinant SARS-Cov-2 Spike RBD protein, C-hFc (HEK293) |
Tag | C-hFc |
Concentration | >0.5 mg/ml |
Form/Appearance | Lyophilized or Liquid |
Purity | > 95% as determined by SDS-PAGE |
MW | 50 kDa |
Target | Spike glycoprotein |
Protein Sequence | 319-541/1273 |
Expression System | HEK293 cell |
Biological Activity | Yes |
Endotoxins | Not analyzed |
Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
Buffer/Preservatives | Lyophilized from 0.22um filtered solution in PBS (pH7.4). Normally 5% trehalose is added as protectant before lyophilization. |
Alternative names | Recombinant SARS-CoV-2 Spike RBD (C-hFc-Tag,HEK293 Read more... |
Note | For research use only |
Application notes | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Expiration Date | 6 months from date of receipt. |
98.00% | |
51.7 kDa (predicted). Due to glycosylation, the protein migrates to 60-62 kDa based on Tris-Bis PAGE result. |
98.00% | |
102.6 kDa (predicted). Due to glycosylation, the protein migrates to 130-140 kDa based on Tris-Bis PAGE result. |
98.00% | |
102.6 kDa (predicted). Due to glycosylation, the protein migrates to 130-140 kDa based on Tris-Bis PAGE result. |